The AT2G07725 antibody is a research tool designed to specifically recognize and bind to the 60S ribosomal protein L5 located in plant mitochondria. This antibody targets a critical component of the mitochondrial ribosomal machinery involved in protein synthesis within the organelle. The antibody was generated using synthetic peptides that share 100% sequence homology with the RPL5 protein sequence (ATMG00210), making it highly specific for research applications examining mitochondrial ribosomal structure and function in plants .
The AT2G07725 antibody demonstrates extensive cross-reactivity across multiple plant species due to the high conservation of the ribosomal L5 protein sequence. Based on empirical testing, the antibody effectively recognizes target proteins in the following species:
Product Code | Confirmed Cross-Reactive Species |
---|---|
PHY7324S | Arabidopsis thaliana, Brassica napus, Brassica rapa, Solanum tuberosum, Glycine max, Nicotiana tabacum, Solanum lycopersicum, Vitis vinifera, Medicago truncatula, Oryza sativa, Triticum aestivum, Gossypium raimondii |
PHY7325S | Arabidopsis thaliana, Glycine max, Gossypium raimondii, Brassica napus, Brassica rapa, Vitis vinifera, Spinacia oleracea, Medicago truncatula, Solanum tuberosum, Nicotiana tabacum, Solanum lycopersicum, Cucumis sativus |
This broad cross-reactivity makes the antibody a versatile tool for comparative studies across different plant taxa .
For optimal antibody performance and longevity, the AT2G07725 antibody should be stored according to these evidence-based protocols:
Upon receipt, immediately store the lyophilized antibody in a manual defrost freezer
Minimize freeze-thaw cycles as they significantly degrade antibody function and specificity
When thawing for use, maintain at 4°C during experimental procedures
For long-term storage, aliquot reconstituted antibody to minimize freeze-thaw cycles
Document storage conditions and freeze-thaw events to correlate with experimental performance
Following these storage protocols has been demonstrated to preserve antibody activity and reduce batch-to-batch variation in experimental outcomes .
Establishing optimal antibody dilution is critical for achieving robust and reproducible results. The following methodological approach is recommended:
Perform a preliminary dilution series (1:100, 1:500, 1:1000, 1:5000) for your specific application
Include both positive and negative controls to establish signal-to-noise ratio
For Western blotting: Begin with 1:1000 dilution in 5% BSA or milk blocker
For immunohistochemistry: Start with 1:200 dilution and adjust based on signal intensity
For ELISA applications: Test dilutions between 1:500 and 1:2000
Optimized dilution factors should be determined empirically for each experimental technique, cell/tissue type, and detection system to ensure balance between specific signal and background noise .
For complex multi-parameter immunofluorescence experiments examining plant mitochondrial complexes, researchers should employ this methodological workflow:
Sample preparation optimization:
Use fresh tissue samples or properly fixed specimens (4% paraformaldehyde for 15-20 minutes)
Perform antigen retrieval using citrate buffer (pH 6.0) heating method if necessary
Include permeabilization step with 0.1% Triton X-100 to facilitate antibody access to mitochondrial targets
Antibody multiplexing strategy:
Utilize AT2G07725 as primary antibody in combination with antibodies against other mitochondrial components
Select complementary fluorophore-conjugated secondary antibodies with minimal spectral overlap
Implement sequential staining for antibodies derived from the same species
Include DAPI nuclear counterstain and MitoTracker for organelle localization
Control implementation:
Run parallel slides with isotype controls at matching concentrations
Include single-antibody controls to assess bleed-through in multiplexed channels
Prepare absorption controls using immunizing peptide
This methodological approach enables visualization of L5 protein in context with other mitochondrial components, providing insights into ribosomal assembly and function .
When investigating low-abundance mitochondrial ribosomal proteins, researchers can employ these advanced techniques to enhance detection sensitivity:
Sample enrichment:
Perform mitochondrial isolation using differential centrifugation
Further fractionate mitochondrial lysates to concentrate ribosomal components
Implement immunoprecipitation to concentrate target proteins before analysis
Signal amplification methods:
Utilize tyramide signal amplification (TSA) for immunohistochemistry
Employ biotin-streptavidin amplification systems
Consider implementing quantum dot-conjugated secondary antibodies for enhanced signal stability
Detection optimization:
Use highly sensitive ECL substrates for Western blotting
Extend primary antibody incubation time (overnight at 4°C)
Implement epitope retrieval techniques specific for mitochondrial proteins
These methodological enhancements have demonstrated up to 10-fold increases in detection sensitivity for low-abundance mitochondrial proteins like L5 .
Rigorous validation of antibody specificity is essential for reliable research outcomes. For AT2G07725 antibody, implement this comprehensive validation workflow:
Western blot analysis:
Confirm single band at expected molecular weight (~34 kDa for L5)
Test with recombinant protein controls
Compare reactivity in wild-type vs. L5 knockdown/knockout models
Peptide competition assay:
Pre-incubate antibody with excess immunizing peptide
Parallel testing of blocked vs. unblocked antibody
Evaluate signal reduction to confirm epitope specificity
Mass spectrometry validation:
Immunoprecipitate target protein using AT2G07725 antibody
Perform LC-MS/MS analysis of precipitated proteins
Confirm presence of target protein and associated complex components
Orthogonal method correlation:
Compare protein detection with alternative antibodies targeting different epitopes
Correlate protein levels with mRNA expression data
Use GFP-tagged constructs as complementary detection method
Maintaining experimental reproducibility across antibody batches requires systematic quality control measures:
Reference standard creation:
Establish a well-characterized positive control sample
Create sufficient aliquots for testing multiple antibody batches
Document signal intensity under standardized conditions
Quantitative comparison protocol:
Perform side-by-side testing of new and reference antibody batches
Use quantitative Western blot or ELISA to determine relative potency
Calculate a normalization factor if necessary for data consistency
Specificity confirmation:
Verify that epitope recognition pattern remains consistent
Check for any new non-specific bands or cross-reactivity
Confirm signal-to-noise ratio meets established thresholds
Implementation of these quality control measures minimizes experimental variability and enhances data reproducibility across extended research projects .
False negative results when using AT2G07725 antibody can stem from multiple methodological factors. The following systematic approach addresses common issues:
Problem | Potential Causes | Recommended Solutions |
---|---|---|
No signal in Western blot | Ineffective protein transfer | - Verify transfer using reversible stain - Optimize transfer conditions for high MW proteins - Consider alternative membrane types |
Epitope masking/destruction | - Test multiple sample preparation methods - Verify sample buffer composition - Avoid excessive heating during denaturation | |
Insufficient antibody concentration | - Systematically test higher antibody concentrations - Extend primary antibody incubation time - Implement signal amplification systems | |
No signal in immunofluorescence | Inadequate fixation/permeabilization | - Compare multiple fixation protocols - Optimize permeabilization conditions - Test antigen retrieval methods |
Epitope inaccessibility | - Try alternative primary antibodies - Implement longer antibody incubation periods - Test alternative detection methods |
This structured approach allows researchers to systematically isolate and address technical issues affecting experimental outcomes .
Optimizing signal-to-noise ratio is crucial for generating publication-quality data. Implement these evidence-based strategies:
Blocking optimization:
Compare different blocking agents (BSA, milk, commercial blockers)
Titrate blocking agent concentration (1-5%)
Extend blocking time to reduce non-specific binding
Washing protocol refinement:
Increase washing buffer volume and duration
Add detergents (0.05-0.1% Tween-20) to reduce hydrophobic interactions
Implement additional washing steps after secondary antibody incubation
Antibody preparation:
Pre-adsorb antibodies against common cross-reactive components
Centrifuge antibody solutions before use to remove aggregates
Prepare fresh dilutions for each experiment
Detection system optimization:
Select detection reagents matched to expression level
Use enzyme substrates with lower background characteristics
Implement shorter substrate development times with monitoring
These methodological refinements significantly enhance signal specificity while minimizing background interference .
The AT2G07725 antibody offers valuable research applications for investigating mitochondrial ribosomal responses to environmental stressors:
Experimental design for stress response studies:
Establish baseline L5 protein expression under normal conditions
Apply controlled stress treatments (drought, salt, temperature, oxidative stress)
Track temporal changes in L5 protein levels, post-translational modifications, and localization
Multi-omics integration approach:
Correlate L5 protein levels with transcriptomic changes in nuclear and mitochondrial genes
Analyze mitochondrial translation efficiency under stress conditions
Assess impacts on respiratory complex assembly and function
Comparative analysis across species:
Leverage the broad cross-reactivity to examine evolutionary conservation of stress responses
Compare L5 dynamics across species with different stress tolerance mechanisms
Identify potential regulatory patterns for mitochondrial translation during stress adaptation
This research approach provides insights into how plant mitochondrial translation machinery responds to environmental challenges, with potential applications for crop improvement .
Co-immunoprecipitation (Co-IP) with AT2G07725 antibody enables investigation of mitochondrial ribosomal protein interactions. Researchers should implement this methodological framework:
Sample preparation optimization:
Utilize gentle lysis buffers to preserve protein-protein interactions
Include protease and phosphatase inhibitors to maintain complex integrity
Test different detergent types and concentrations to balance solubilization and complex preservation
Antibody immobilization strategies:
Compare direct antibody conjugation vs. protein A/G approaches
Optimize antibody-to-bead ratio (typically 5-10 μg antibody per 50 μl bead volume)
Determine ideal cross-linking conditions if needed to prevent antibody leaching
Interaction validation:
Implement reciprocal Co-IP with antibodies against suspected interaction partners
Include appropriate negative controls (isotype antibodies, irrelevant targets)
Perform stringency washes to eliminate non-specific binding
Analysis considerations:
Use mass spectrometry for unbiased identification of interaction partners
Validate key interactions with orthogonal methods (proximity ligation, FRET)
Assess interaction dynamics under different physiological conditions
This structured Co-IP methodology facilitates reliable characterization of mitochondrial ribosomal complexes and their dynamic regulation .
While traditional antibodies like AT2G07725 have been research mainstays, emerging nanobody technology offers potential advantages for mitochondrial research:
Nanobody advantages for mitochondrial applications:
Smaller size (12-15 kDa vs. 150 kDa) enables better penetration into mitochondrial structures
Enhanced recognition of conformational epitopes in native protein complexes
Greater stability under various experimental conditions
Potential for intracellular expression as research tools
Development considerations:
Generation of nanobodies against AT2G07725 target epitopes
Validation against traditional antibody performance
Optimization for live-cell imaging applications
Research applications:
Super-resolution microscopy of mitochondrial ribosome dynamics
Intracellular tracking of ribosomal assembly
Targeted modulation of mitochondrial translation
The integration of nanobody technology represents a promising frontier for enhancing mitochondrial ribosomal protein research with improved spatial and temporal resolution .
Advanced computational methods offer opportunities to improve antibody research tools and applications:
Structure-based antibody engineering:
Computational prediction of epitope accessibility in target proteins
In silico affinity maturation to enhance binding properties
Design of antibodies targeting conformational epitopes in ribosomes
Application in experimental design:
Modeling of antibody binding to complex ribosomal structures
Prediction of optimal epitope targeting for specific applications
Computational assessment of cross-reactivity with related proteins
Integration with experimental data:
Combining structural modeling with empirical binding data
Refinement of antibody properties based on experimental feedback
Development of improved variants through iterative computational design
These computational approaches can assist in developing next-generation antibody tools with enhanced specificity, affinity, and application-specific performance characteristics .